Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1931-1940 of 2489 for

Edit search filters
  1. A Study To Evaluate Circulating Cell Free Tumor DNA As A Biomarker In Sarcoma

    Rochester, MN

  2. ROR1771: A Prospective Observational Study Of Proton Stereotactic Body Radiation Therapy And Immunotherapy For Recurrent/Progressive Locoregional Or Metastatic Head And Neck Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  3. A Study To Determine Baseline Levels For Prostate Cancer-Derived Particles Containing Cellular Matter (Extracellular Vesicles) After Local Treatment

    Rochester, MN

  4. A Study To Evaluate Factors In Breast Cancer Screening Among Asian Americans In Olmsted And Surrounding Counties

    Rochester, MN

  5. A Study To Detect Cancers Through Elective Plasma-based CancerSEEK Testing

    Albert Lea, MN, Scottsdale/Phoenix, AZ, Eau Claire, WI, La Crosse, WI, Mankato, MN, Rochester, MN

  6. Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments

    Jacksonville, FL

  7. Monoclonal Proteins by Blood Spot and Saliva

    Rochester, MN

  8. Subepithelial Esophageal Lesions: The Mayo Clinic Experience

    Rochester, MN

  9. A Study of Adherence Scores and Patient Satisfaction Scores to Oral Chemotherapy for Patients followed by a Pharmacist in an Outpatient Cancer Center

    Scottsdale/Phoenix, AZ

  10. Preclinical drug testing and assay development for lung adenocarcinoma characterized by the expression of ASCL1

    Rochester, MN

.

Mayo Clinic Footer